期刊文献+

Combretastatin A-4顺式锁定衍生化研究进展 被引量:1

Progress in cis-Restricted Derivations of Combretastatin A-4
下载PDF
导出
摘要 Combretastatin A-4(CA4)是天然抗肿瘤化合物,其顺式二苯乙烯构型对活性起关键作用。采用环状结构进行CA4的顺式构型锁定已成为目前结构改造的主要思路。本文从三元环、五元环、六元环锁定及骨架延伸锁定等方面综述了近年来CA4烯碳桥顺式锁定改造及衍生化的研究进展。 Combretastatin A-4 (CA4) is an important new generation vascular disrupting agent (VDA) from plant. The cis-stilbene configuration of which plays a crucial role on antitumor and anti-vascular activities. The ring formation in ethylene moiety has been considered to be the main idea for structure modification of CA4. The recent progress in cis-restricted derivations of CA4 representing by three, five, six-membered ring formation as well as skeleton extension has been reviewed.
出处 《天然产物研究与开发》 CAS CSCD 2011年第1期169-185,152,共18页 Natural Product Research and Development
基金 广东省科技计划项目(2003B31603 2006B35604002) 广州市科技计划项目(2007J1-C0261) 国家科技支撑计划项目(2007BAD82B02) 广东省中国科学院全面战略合作项目(2009B091300125)
关键词 COMBRETASTATIN A-4 构效关系 顺式锁定 衍生化 血管阻断剂 combretastatin A-4 SAR cis-restriction derivation VDA
  • 相关文献

参考文献34

  • 1Pettit GR,et al.Isolation and structure of the strong cell growth and tubulin inhibitor Combretastatin A-4.Experientia,1989,45:209-211.
  • 2Lin CM,et al.Antimitotic natural products combretastatin A-4 and combretastatin A-2:studies on the mechanism of their inhibition of the binding of colchicine to tubulin.Biochemistry,1989,28:6984-6991.
  • 3Hori K,et al.Antitumor effects due to irreversible stoppage of tumor tissue blood flow:evaluation of a novel combretastatin A-4 derivative,AC7700.Jpn J Cancer Res,1999,90:1026-1038.
  • 4Nihei Y,et al.A novel combretastatin A-4 derivative,AC7700,shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.Jpn J Cancer Res,1999,90:1016-1025.
  • 5Tozer GM,et al.Combretastatin A-4 phosphate as a tumor vascular-targeting agent:early effects in tumors and normal tissues.Cancer Res,1999,59:1626-1634.
  • 6Pettit GR,Rhodes MR.Antineoplastic agents 389.new syntheses of the combretastatin A-4 prodrug.Anti-Cancer Drug Design,1998,13:183-191.
  • 7Woods JA,et al.The interaction with tubulin of series of stilbenes based on combretastatin A-4.Br J Cancer,1995,71:705-711.
  • 8Hadfield JA,et al.Synthesis and evaluation of double bond substituted combretastatins.Eur J Med Chem,2005,40:529-541.
  • 9Shirai R,et al.Asymmetric synthesis of anti-mitotic combretadioxolane with potent anti-tumor activity agginst multidrug resistant cells.Bioorg Med Chem Lett,1998,8:1997-2000.
  • 10Nam NH,et al.Combretoxazolones:synthesis,cytotoxicity and antitumor activity.Bioorg & Med Chem Lett,2001,11:3073-3076.

同被引文献3

  • 1Pettit G R.Isolation and structure of the strong cell growth and tubulin inhibitor Combretastatin A-4[J]. Fxperientia,1989,45:209-211.
  • 2Dark G G, Hill S A, et al. Combretastatin A-4 an agent that displays potent and selective toxicity toward tumor vasculature [J]. Cancer Res, 1997,57:1829-1834.
  • 3Bohle A S,Leuschner I,Kalthoff H,et al. Combretastatin A-4 prodrug a potent inhibitor of malignant hemangioendothelioma cell proliferation [J].lnt J Cancer,2000,87(6):838-843.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部